Clinical trial
CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
NCT00272584 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00272584 |
|---|---|
| Title | CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia |
| Official title | International Study of Improving Treatment for the Most Severely Ill With Schizophrenia |
| Lead sponsor | University of British Columbia, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psychosis, Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 100 |
| Start date | Jun 1, 2001 |
| Completion | Jan 1, 2004 |
| First posted | Jan 6, 2006 |
| Last update posted | May 8, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: